Estimate Recalculated Apr 1, 2025 09:49PM EST
Daniel D Burgess does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Nabriva Therapeutics Plc, Arbutus Biopharma Corp, Nabriva Therapeutics plc, Cidara Therapeutics, Inc., SANTARUS INC, METABASIS THERAPEUTICS INC, and HOLLIS EDEN PHARMACEUTICALS INC /DE/.
Daniel D Burgess's CIK is 0001239650
2013 was Daniel D Burgess's most active year for acquiring shares with 7 total transactions. Daniel D Burgess's most active month to acquire stocks was the month of May. 2013 was Daniel D Burgess's most active year for disposing of shares, totalling 11 transactions. Daniel D Burgess's most active month to dispose stocks was the month of December. 2018 saw Daniel D Burgess paying a total of $99,000.00 for 113,000 shares, this is the most they've acquired in one year. In 2014 Daniel D Burgess cashed out on 378,000 shares for a total of $9,712,840.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!